Podcasts about series motherhood channel health

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

AI-powered cell imaging may help researchers identify biological differences that are difficult or impossible to see by eye. Yu-Hwa Lo, Ph.D., and Louise Laurent, M.D., Ph.D., describe a system that combines high-speed imaging, cell sorting, microfluidics, and artificial intelligence. The technology creates label-free images of cells, uses AI to classify them, and can isolate selected cells for deeper molecular analysis. Laurent explains how the team is applying the system to human trophoblast stem cells, which give rise to specialized placental cells involved in nutrient transport, hormone production, blood vessel remodeling, and immune regulation. Lo describes how AI can distinguish cell populations and identify features that may not be apparent to human observers. The researchers ultimately hope to connect imaging features with gene expression, proteins, and metabolism, allowing cell characteristics and behavior to be predicted from images alone. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41637]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Continuous glucose monitoring and wearable data are changing how researchers study pregnancy and women's health. Gladys (Sandy) Ramos, M.D., explains why glucose control is difficult during pregnancy and how CGM can reveal patterns that finger-stick testing may miss. She also describes research on CGM use in type 2 and gestational diabetes, labor, and behavior change. Ben Smarr, Ph.D., shows how wearable data can track changes in temperature, heart rate, activity, respiration, menstrual cycles, pregnancy, and aging. Together, the speakers discuss personalized care, participant engagement, patient-driven innovation, and access to these tools. The goal is to learn from continuous data while recognizing limits in evidence, interpretation, and equity. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41636]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Men with non-obstructive azoospermia may undergo microscopic testicular sperm extraction, or mTESE, without knowing whether sperm will be found. Kun Tan, Ph.D., of UC San Diego explains how molecular semen analysis could provide a noninvasive way to predict the procedure's outcome. The assay uses stage-specific germ cell markers identified through single-cell RNA sequencing, then measures those markers in semen with qPCR. Because semen contains germ cells from different stages of sperm development, their molecular signals may reflect what is happening inside the testes. Tan shows how the assay predicts whether sperm retrieval was successful and can identify where sperm development may be blocked. The research could help couples planning IVF or ICSI avoid unnecessary surgery, reduce financial and emotional burdens, and receive more detailed information about male infertility before treatment. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41630]

Menopause can affect sexual health in ways that are common, frustrating, and often overlooked. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal changes during perimenopause and menopause contribute to vaginal dryness, pain with intercourse, and low libido. Macaulay also outlines why these symptoms can have more than one cause, including physical changes, life stressors, relationship factors, and other health conditions. This discussion helps clarify that sexual symptoms during menopause are common and treatable, and it points toward more informed conversations with a health care provider. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41523]

Menopause can affect sexual health in ways that are common, frustrating, and often overlooked. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal changes during perimenopause and menopause contribute to vaginal dryness, pain with intercourse, and low libido. Macaulay also outlines why these symptoms can have more than one cause, including physical changes, life stressors, relationship factors, and other health conditions. This discussion helps clarify that sexual symptoms during menopause are common and treatable, and it points toward more informed conversations with a health care provider. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41523]

Menopause can affect sexual health in ways that are common, frustrating, and often overlooked. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal changes during perimenopause and menopause contribute to vaginal dryness, pain with intercourse, and low libido. Macaulay also outlines why these symptoms can have more than one cause, including physical changes, life stressors, relationship factors, and other health conditions. This discussion helps clarify that sexual symptoms during menopause are common and treatable, and it points toward more informed conversations with a health care provider. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41523]

Menopause can affect sexual health in ways that are common, frustrating, and often overlooked. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal changes during perimenopause and menopause contribute to vaginal dryness, pain with intercourse, and low libido. Macaulay also outlines why these symptoms can have more than one cause, including physical changes, life stressors, relationship factors, and other health conditions. This discussion helps clarify that sexual symptoms during menopause are common and treatable, and it points toward more informed conversations with a health care provider. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41523]

Menopause symptoms can affect sleep, mood, and everyday quality of life in ways that are easy to dismiss but hard to ignore. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains what menopause is, when hormone therapy is considered, and why treatment decisions depend on symptoms, health history, and individual risk. Macaulay also addresses hot flashes, night sweats, osteoporosis prevention, and the factors that shape whether hormone therapy is a good option. She helps clarify why menopause care is not one size fits all and points toward more informed conversations about symptom relief and long-term health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41521]

Menopause symptoms can affect sleep, mood, and everyday quality of life in ways that are easy to dismiss but hard to ignore. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains what menopause is, when hormone therapy is considered, and why treatment decisions depend on symptoms, health history, and individual risk. Macaulay also addresses hot flashes, night sweats, osteoporosis prevention, and the factors that shape whether hormone therapy is a good option. She helps clarify why menopause care is not one size fits all and points toward more informed conversations about symptom relief and long-term health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41521]

Menopause symptoms can affect sleep, mood, and everyday quality of life in ways that are easy to dismiss but hard to ignore. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains what menopause is, when hormone therapy is considered, and why treatment decisions depend on symptoms, health history, and individual risk. Macaulay also addresses hot flashes, night sweats, osteoporosis prevention, and the factors that shape whether hormone therapy is a good option. She helps clarify why menopause care is not one size fits all and points toward more informed conversations about symptom relief and long-term health. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41521]

Perimenopause can bring physical and emotional changes that leave many women feeling unsettled. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal shifts and changing menstrual cycles shape this stage of life. Macaulay examines symptoms such as irregular periods, hot flashes, and mood changes, along with broader concerns including weight, overall health, and contraception. This discussion helps clarify why symptoms vary widely, why care should be individualized, and why women do not need to panic as they move through this transition. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41362]

Academic medicine affects patient care in important ways. Julia Cormano, M.D., F.A.C.O.G., Assistant Dean for Clinical Curriculum, Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences, UC San Diego, explains how medical students, resident physicians, and fellows contribute to care in a supervised teaching hospital environment. Cormano defines the role of each learner, outlines how they participate in hospitals and clinics, and shows how team-based care can bring more attention, more listening, and up-to-date medical knowledge to each patient's case. She also explains that attending physicians oversee every decision, combining experienced judgment with the energy and perspective of learners. This work helps clarify how academic medicine supports both patient care and physician training and points toward a broader understanding of why teaching hospitals play an important role in healthcare. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41180]

Perimenopause can bring physical and emotional changes that leave many women feeling unsettled. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal shifts and changing menstrual cycles shape this stage of life. Macaulay examines symptoms such as irregular periods, hot flashes, and mood changes, along with broader concerns including weight, overall health, and contraception. This discussion helps clarify why symptoms vary widely, why care should be individualized, and why women do not need to panic as they move through this transition. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41362]

Academic medicine affects patient care in important ways. Julia Cormano, M.D., F.A.C.O.G., Assistant Dean for Clinical Curriculum, Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences, UC San Diego, explains how medical students, resident physicians, and fellows contribute to care in a supervised teaching hospital environment. Cormano defines the role of each learner, outlines how they participate in hospitals and clinics, and shows how team-based care can bring more attention, more listening, and up-to-date medical knowledge to each patient's case. She also explains that attending physicians oversee every decision, combining experienced judgment with the energy and perspective of learners. This work helps clarify how academic medicine supports both patient care and physician training and points toward a broader understanding of why teaching hospitals play an important role in healthcare. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41180]

Perimenopause can bring physical and emotional changes that leave many women feeling unsettled. Kathryn Macaulay, M.D., Director, UC San Diego Menopause Health Program, explains how hormonal shifts and changing menstrual cycles shape this stage of life. Macaulay examines symptoms such as irregular periods, hot flashes, and mood changes, along with broader concerns including weight, overall health, and contraception. This discussion helps clarify why symptoms vary widely, why care should be individualized, and why women do not need to panic as they move through this transition. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41362]

Academic medicine affects patient care in important ways. Julia Cormano, M.D., F.A.C.O.G., Assistant Dean for Clinical Curriculum, Associate Professor of Obstetrics, Gynecology, & Reproductive Sciences, UC San Diego, explains how medical students, resident physicians, and fellows contribute to care in a supervised teaching hospital environment. Cormano defines the role of each learner, outlines how they participate in hospitals and clinics, and shows how team-based care can bring more attention, more listening, and up-to-date medical knowledge to each patient's case. She also explains that attending physicians oversee every decision, combining experienced judgment with the energy and perspective of learners. This work helps clarify how academic medicine supports both patient care and physician training and points toward a broader understanding of why teaching hospitals play an important role in healthcare. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41180]